I am very pleased with the service I get from Curant Health. I cannot speak highly enough of the customer service I receive.

— Charles S., Florida



Value-based Contracting 2.0: Is Specialty Pharmacy Ready for its Shot at the Spotlight?

February 13 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - In December 2016, QuintilesIMS reported that US spending on prescription medications will reach upwards of $675 billion by 2021. The pricing pressure on manufacturers is expected to grow along with the demand that specialty therapies, in particular, demonstrate positive outcomes in real-world... read more

Value-based care takes over J.P. Morgan 35th Annual Healthcare Conference 2017

January 23, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Despite news breaking on the first steps toward the repeal of the Affordable Care Act (ACA) and President-elect Trump’s comments on pharmaceutical manufacturers and pricing, not all was doom and gloom at the J.P. Morgan 35th Annual Healthcare Conference 2017, January 9-12,... read more


January 3, 2017 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of seven 340B clinic partnerships in January 1, 2017: Family Centers Health Care - Greenwich, Connecticut Florida Department of Health, Lee County - Fort Myers, Florida Florida Department of Health, Palm Beach County -... read more

Three issues to watch at the J.P. Morgan Healthcare Conference 2017

January 3, 2017 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Every year, the business of healthcare gathers en masse at the annual J.P. Morgan Healthcare Conference. This year’s conference will be held January 9 to January 12 in San Francisco. What will we learn? What will we hear? What will be... read more

Four things to know about the 21st Century Cures Act

December 14, 2016 - Curant Health Director of Commercial Strategy and Performance, Jake Caines, featured in Managed Healthcare Executive - Congress has approved the 21st Century Cures Act, which aims to speed federal approval of new drugs and devices as well as beef up funding of medical research. It is expected that President Obama will... read more

What billions in lost pharmaceutical revenue means for managed care

December 12, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - In November CapGemini and HealthPrize Technologies updated the forward to a reissued 2012 report on pharmaceutical revenue loss due to medication nonadherence that states, “Globally, according to CMR International, pharma revenues hit $1.1 trillion in 2015, which is a 13% increase... read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or klindsey@curanthealth.com

Menu Title